Search results for “PRAME” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 233 patents, we discovered top 38 key players by total patent application. GlaxoSmithKline Biologicals SA, Immatics Biotechnologies GmbH, BioNTech SE are dominant in this area. They take 40.34% of the total patent filing.
GlaxoSmithKline Biologicals SA
Belgium
Patent: 44
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 32
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 18
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 15
MannKind Corp.
California, United States
Patent: 15
Xiangxue Life Science Technology (Guangdong) Co., Ltd.
Guangdong Sheng, China
Patent: 15
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 14
Immunocore Ltd.
United Kingdom
Patent: 10
Eureka Therapeutics, Inc.
California, United States
Patent: 6
Lucence Life Sciences Pte Ltd.
Central Singapore, Singapore
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 134 patents applied in the last 5 years. We discover 23 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, BioNTech SE, Inovio Pharmaceuticals, Inc. take 47.01% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 31
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 18
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 14
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 14
Immunocore Ltd.
United Kingdom
Patent: 10
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 8
Children's National Hospital (District of Columbia)
District of Columbia, United States
Patent: 6
Medigene Immunotherapies GmbH
Germany
Patent: 5
Academisch Ziekenhuis Maastricht
Netherlands
Patent: 2
Xiangxue Life Science Technology (Guangdong) Co., Ltd.
Guangdong Sheng, China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 134 patents in last 5 years, we discover 15 new entrants. BioNTech SE, Inovio Pharmaceuticals, Inc., Immunocore Ltd. are the most active new entrants in this area.
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 18
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 14
Immunocore Ltd.
United Kingdom
Patent: 10
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 8
Medigene Immunotherapies GmbH
Germany
Patent: 5
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 2
Hangzhou Kaibaoluo Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Eutilex Co., Ltd.
South Korea
Patent: 1
bluebird bio, Inc.
Massachusetts, United States
Patent: 1
Mie University
Mie-ken, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 29 patents, we discovered top 5 universities and scientific research institutions by total patent application. Louisiana State University, Emory University, President & Fellows of Harvard College are dominant in this area. They take 72.41% of the total patent filing.
Louisiana State University
Louisiana, United States
Patent: 1
Emory University
Georgia, United States
Patent: 1
President & Fellows of Harvard College
Massachusetts, United States
Patent: 1
Mie University
Mie-ken, Japan
Patent: 1
Kansai Medical University
Osaka-fu, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: